Docs Debate Insulin vs GLP-1 Agonist as First Injectable for T2D Docs Debate Insulin vs GLP-1 Agonist as First Injectable for T2D

Two experts debated the statement, which arose from the ADA/EASD type 2 diabetes joint consensus statement, that GLP-1 agonists are preferred to insulin as the first-line injectable medication.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news